Drugs / S-3,4-methylenedioxymethamphetamine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06905652 | Jul 2025 → May 2026 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 1 | NCT05277636 | Oct 2022 → Jan 2024 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-3,4-methylenedioxymethamphetamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05277636 ↗ |